Proposed $6.5 Billion Settlement by Johnson & Johnson's Subsidiary for Talc Ovarian Cancer Lawsuits
Wednesday, 1 May 2024, 18:57
Johnson & Johnson's $6.5 Billion Talc Lawsuit Settlement
A subsidiary of Johnson & Johnson (J&J) is proposing to pay more than $6.5 billion to resolve nearly all the talc ovarian cancer lawsuits brought against the company.
Details of the Settlement
- J&J plans to pay about $6.475 billion over 25 years to settle most pending lawsuits related to its talc-based baby powder.
- The strategy aims to address 99.75% of the pending lawsuits through a structured payout plan.
Conclusion: The proposed settlement by J&J's subsidiary signifies a significant step in resolving the talc ovarian cancer lawsuits, with a focus on consensual agreements and claimant input to move forward.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.